Denali-Sanofi scraps mid-stage study for multiple sclerosis drug-March 2024-www.financetom.com

Denali-Sanofi scraps mid-stage study for multiple sclerosis drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Denali-Sanofi scraps mid-stage study for multiple sclerosis drug

Oct 10, 2024 6:09 PM

Oct 10 (Reuters) - Drug developer Denali Therapeutics ( DNLI )

said on Thursday its partner Sanofi has

discontinued a mid-stage study testing their experimental drug

to treat multiple sclerosis as it failed to meet the main and

secondary goals.

Previous page： SC asks Centre to file status report on proceedings in UK for extradition of Vijay Mallya Next page： In Kanchipuram, COVID-19 has dealt a death-blow to handloom weavers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SC asks Centre to file status report on proceedings in UK for extradition of Vijay Mallya

Nov 2, 2020

The Centre had on October 5 told the apex court that Mallya cannot be extradited to India until a separate secret legal process in the United Kingdom, which is judicial and confidential in nature is resolved.

In Kanchipuram, COVID-19 has dealt a death-blow to handloom weavers

Oct 29, 2020

This year, the COVID-19 pandemic saw sales of Kanjeevaram sarees fall drastically, thanks to low-key wedding ceremonies and a consumption slowdown.

Restarting India: Will 'revenge travel' accelerate travel and hospitality industry's revival?

Nov 2, 2020

As more people are taking to the skies and "revenge travel" is becoming a buzz word, what would it take for the travel and hospitality industry to bounce back from the COVID slump? CNBC-TV18’s Shereen Bhan finds out from Ronojoy Dutta, CEO of IndiGo; Puneet Chhatwal, MD & CEO of Indian Hotels; and Deep Kalra, Chairman & Group CEO of MakeMyTrip.

CCPL partners with Denmark's Tuco Marine to build patrol boats

Nov 2, 2020

Chowgule and Company Pvt Ltd (CCPL) on Monday said it has partnered with Denmark's Tuco Marine Group to build advanced patrol boats in India. The 16metrelong patrol boats, designed as per Tuco Marine's ProZero concept, will strengthen CCPL's existing business of manufacturing composite fibrereinforced plastic (FRP) boats, it added.